Key result
Using an NT-proBNP cut-off of ≥125 ng/L for systematic atrial fibrillation screening yielded a negative predictive value of 92%, reducing the number of participants needing screening by 35%.
Why the study?
Does NT-proBNP assessment improve the efficiency of systematic screening for atrial fibrillation in older adults?
Observational (n=886)
Does NT-proBNP assessment improve the efficiency of systematic screening for atrial fibrillation in older adults?
Using NT-proBNP as a pre-screening tool with a cut-off of ≥125 ng/L can safely reduce the number of individuals requiring systematic ECG screening for atrial fibrillation by 35%.
Answers are grounded in this paper and cite their sources.
May streamline AF screening; leaves open outcome benefits in randomized trials.
OBJECTIVE: Screening for atrial fibrillation (AF) in individuals aged 65 and above is recommended by the European Society of Cardiology. Increased levels of the biomarker N-terminal pro B-type natriuretic peptide (NT-proBNP) has in cohort studies been associated with incident AF.The aim of this study was to assess whether NT-proBNP could be useful for AF detection in systematic screening. METHODS: The Strokestop study entailed 7173 Swedish residents aged 75/76 that were screened for AF using twice daily intermittent ECG recordings during 2 weeks. In a substudy of 886 participants, the last 815 consecutive participants and 71 individuals with newly detected AF, levels of NT-proBNP were determined. Using an NT-proBNP cut-off of ≥125 ng/L in a non-acute setting yielded a negative predictive value of 92%, meaning that 35% fewer participants would need to be screened when applied to systematic AF screening. Adding weight to NT-proBNP further reduced participants needed to be screened with a preserved sensitivity. CONCLUSIONS: NT-proBNP was increased in individuals with newly detected AF. Prospective studies could clarify if NT-proBNP can be used to correctly select individuals that benefit most from AF screening. CLINICAL TRIALS: ClinicalTrials.gov. Identifier: NCT01593553.
No takes yet. Share an insight, caveat, or question.
Svennberg et al. (2017) conducted an observational in Atrial fibrillation (n=886). NT-proBNP assessment was evaluated on Negative predictive value of NT-proBNP cut-off ≥125 ng/L for AF detection (NPV 92%). Using an NT-proBNP cut-off of ≥125 ng/L for systematic atrial fibrillation screening yielded a negative predictive value of 92%, reducing the number of participants needing screening by 35%.
Synapse has enriched 10 related papers. Consider them for comparative context: